|Bid||564.40 x 800|
|Ask||574.00 x 1100|
|Day's range||562.52 - 570.91|
|52-week range||441.00 - 686.62|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||10.28|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||690.00|
Regeneron (REGN) and Sanofi's (SNY) Dupixent secures FDA approval to treat children aged 6-11 years with moderate to severe asthma.
In the latest trading session, Regeneron (REGN) closed at $562.71, marking a +1.92% move from the previous day.
Dr. Elizabeth Clayborne, Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and Emergency Physician at UM Capital Region Medical Center, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.